Role of connective tissue growth factor in mediating hypertrophy of human proximal tubular cells induced by angiotensin II

Background/ Aims: Cellular hypertrophy is an early important pathological feature of renal diseases such as diabetic nephropathy and remnant kidney. Recent studies have demonstrated that angiotensin II ( Ang II) might be a major contributor in regulating cell hypertrophy. However, the exact mechanism is still unclear. The aim of our present work was to investigate the possible role of a newly clarified fibrogenic factor, connective tissue growth factor ( CTGF), in mediating the effect of Ang II-induced tubular cell hypertrophy. Methods: The cell line HK2 was grown in Dulbecco's modified Eagle's medium containing 10% heat- inactivated fetal calf serum. After the cells were rested in serum- free medium for 24 h, the dose and time response of CTGF mRNA expression to Ang II stimulation was observed by RT- PCR, and protein synthesis was observed by Western blotting. The effect of anti-CTGF on Ang II ( 10(-7) M)- induced [H-3]- leucine incorporation, total protein content ( Coomassie brilliant blue G250 method) and change in cellular size [ determined by a scanning electronic microscope ( SEM)] was also observed. The influence of anti- CTGF antibody on the cell cycle was analyzed by using a fluorescence- activated cell sorter flow cytometer. Results: The results showed that Ang II induced expression of CTGF mRNA in a time- and dose- dependent manner ( p < 0.05 and 0.01, respectively). Stimulation of cells with Ang II ( 10 - 7 M) for 48 h resulted in a 92% increase in [ H-3]- leucine incorporation ( 5,584 cpm/ 10(5) cells at 0 h vs. 10,741 cpm/ 10(5) cells at 48 h; p = 0.01), which was significantly abolished by treatment with anti- CTGF antibody. Ang II ( 10 - 7 M) significantly increased the total protein content in HK2 cells ( control: 0.169 +/- 0.011 mg/10(5) cells vs. Ang II: 0.202 +/- 0.010 mg/ 10(5) cells; p = 0.03), which was markedly inhibited by cotreatment with anti- CTGF antibody. The average cellular diameter determined by SEM showed that the increase in cell size induced by Ang II could be significantly inhibited by anti- CTGF antibody ( control: 11.92 =/- 1.62 mu m, Ang II group: 20.63 +/- 3.83 mu m, Ang II + anti-CTGF group: 16.43 +/- 3.23 mu m; p < 0.01, respectively). Furthermore, the flow cytometer study showed that Ang II arrested the cell cycle at G0 - G1 phase, which was significantly reversed by treatment with anti- CTGF antibody ( G0 - G1 percentage: in Ang II group: 76 +/- 1.8%, in Ang II + anti- CTGF group: 71 +/- 1.78%; p = 0.04). Conclusion: Our data are the first to clearly demonstrate that CTGF might be an important mediator of Ang II- induced renal hypertrophy, which suggests that inhibiting the production of CTGF might be the new strategy in early prevention of renal fibrosis. Copyright (C) 2003 S. Karger AG, Basel.